# Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia

> **NCT00887276** · PHASE4 · TERMINATED · sponsor: **University of Ulm** · enrollment: 290 (actual)

## Conditions studied

- Community Acquired Pneumonia

## Interventions

- **DRUG:** Moxifloxacin
- **DRUG:** Ampicillin;Amoxicillin

## Key facts

- **NCT ID:** NCT00887276
- **Lead sponsor:** University of Ulm
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2014-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00887276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00887276, "Study to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin in Hospitalized Patients With Non-severe Community-acquired Pneumonia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00887276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*